MEDCATH CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2010-12-22: Form 8-K; Period of report 2010-12-22; Description 8.01 Other Events; Details 8.01.
- 2010-11-26: Form 8-K; Period of report 2010-11-19; Description 1.01 Entry into a Material Definitive Agreement; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Details 1.01.
- 2010-11-23: Form 8-K; Period of report 2010-11-23; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2010-11-15: Form 8-K; Period of report 2010-11-09; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2010-12-22 | 8-K | 2010-12-22 | 8.01 Other Events | 8.01 MedCath Corporation (“the Company”) is filing this Current Report on Form 8-K to provide supplemental information regarding impairment charges on long-lived assets recorded during the fourth fiscal quarter and full fiscal year ended September 30, 2010 and information related to the estimated net realizable value of intercompany notes outstanding as of September 30, 2010. | g25611e8vk.htm |
| 2010-11-26 | 8-K | 2010-11-19 | 1.01 Entry into a Material Definitive Agreement; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 1.01 Entry into a Material Definitive Agreement. 5.03 MedCath’s Board of Directors also approved on November 19, 2010 an amendment to MedCath’s Bylaws (the “Amendment”) that added a new article to the Bylaws regarding the indemnification and advancement of expenses to “covered persons” (as defined in the Amendment). | g25396e8vk.htm |
| 2010-11-23 | 8-K | 2010-11-23 | 2.02 Results of Operations and Financial Condition | 2.02 On November 23, 2010, MedCath Corporation issued a press release announcing an update to the strategic alternatives process and its results of operations for the fiscal quarter and year ended September 30, 2010. | g25368e8vk.htm |
| 2010-11-15 | 8-K | 2010-11-09 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On November 9, 2010, MedCath Corporation announced the departure of Mr. David Bussone as Executive Vice President and President, Operations Division, effective December 10, 2010. | g25240e8vk.htm |
| 2010-11-09 | 8-K | 2010-11-05 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | g25175e8vk.htm |
| 2010-11-05 | 8-K | 2010-11-01 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets | 1.01 Entry into a Material Definitive Agreement. 2.01 On November 1, 2010 MedCath Corporation (“the Company”) and its physician partners announced the completion of the sale of substantially all the assets of Heart Hospital of Austin (“HHA”) to St. David’s Healthcare Partnership, L.P., LLP (“St. David’s”), effective November 1, 2010. | g25127e8vk.htm |
| 2010-10-05 | 8-K | 2010-10-01 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 On October 4, 2010, MedCath Corporation (“the Company”) announced the completion of the divestiture of its interest in Avera Heart Hospital of South Dakota to Avera McKennan and certain assets of Arizona Heart Hospital, LLC to Vanguard Health Systems. | g24800e8vk.htm |
| 2010-09-01 | 8-K | 2010-08-27 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | g24530e8vk.htm |
| 2010-08-19 | 8-K | 2010-08-13 | 1.01 Entry into a Material Definitive Agreement | 1.01 On August 13, 2010, MedCath entered into a First Amendment (the “Amendment”) to its Amended and Restated Credit Agreement (the “Credit Facility”), dated as of November 10, 2008, among MedCath Corporation, as parent guarantor (“MedCath”), MedCath Holdings Corp., as borrower, certain of the subsidiaries of MedCath party thereto from time to time, as subsidiary guarantors, Bank of America, N.A., as administrative agent, swing line lender and letter of credit issuer, and each of the lenders party thereto from time to time. | g24409e8vk.htm |
| 2010-08-12 | 8-K | 2010-08-06 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | g24321e8vk.htm |
| 2010-08-09 | 8-K | 2010-08-09 | 2.02 Results of Operations and Financial Condition | 2.02 On August 9, 2010, MedCath Corporation issued a press release announcing its results of operations for the fiscal quarter ended June 30, 2010. | g24256e8vk.htm |
| 2010-06-02 | 8-K | 2010-06-01 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On June 1, 2010, MedCath Corporation announced the departure of Mr. Galen Powers as a director, chair of Compliance Committee, and member of Audit and Governance Committees of its board of directors. | g23665e8vk.htm |
| 2010-05-10 | 8-K | 2010-05-10 | 2.02 Results of Operations and Financial Condition | 2.02 On May 6, 2010, MedCath Corporation (the “Company”) furnished to the Securities and Exchange Commission a Form 8-K reporting the issuance of a press release dated May 5, 2010, announcing its results of operations for the fiscal quarter ended March 31, 2010. | g23381e8vk.htm |
| 2010-05-06 | 8-K | 2010-05-05 | 2.02 Results of Operations and Financial Condition | 2.02 On May 5, 2010, MedCath Corporation (“MedCath”) issued a press release announcing its results of operations for its second fiscal quarter ended March 31, 2010. | g23259e8vk.htm |
| 2010-03-05 | 8-K | 2010-03-01 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders | 5.02 On March 1, 2010, Blair W. Todt, Senior Vice President, General Counsel and Secretary resigned from his position with MedCath Corporation (the “Company”). 5.07 The Company’s annual meeting of stockholders was held on March 3, 2010. | g22393e8vk.htm |
| 2010-03-02 | 8-K | 2010-02-25 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 5.02 Effective February 25, 2010, Dr. Edward R. Casas resigned as a member of MedCath Corporation’s (the “Company”) Board of Directors (the “Board”). 8.01 On March 1, 2010, the Company announced that its Board has formed a Strategic Options Committee (the “Committee”) composed solely of independent directors to consider the sale either of the Company or the sale of its individual hospitals and other assets. | g22344e8vk.htm |
| 2010-02-18 | 8-K | 2010-02-18 | 2.02 Results of Operations and Financial Condition | 2.02 On February 17, 2010, MedCath Corporation (“MedCath”) furnished on Form 8-K Consolidated Statements of Operations (Presenting Heart Hospital of Austin as a Discontinued Operation for Each Period Presented) as exhibit 99.2. | g22160e8vk.htm |
| 2010-02-17 | 8-K | 2010-02-17 | 1.01 Entry into a Material Definitive Agreement; 2.02 Results of Operations and Financial Condition | 1.01 Entry into a Material Definitive Agreement. 2.02 Beginning with its second quarter of fiscal 2010, which ends March 31, MedCath will account for Heart Hospital of Austin as an asset-held-for-sale for current and prior reporting periods. | g22140e8vk.htm |
| 2010-02-04 | 8-K | 2010-02-03 | 2.02 Results of Operations and Financial Condition | 2.02 On February 3, 2010, MedCath Corporation (“MedCath”) issued a press release announcing its results of operations for the fiscal quarter ended December 31, 2009. | g21977e8vk.htm |